cobacyteâ„¢

  1. T

    Access Pharmaceuticals ProLindac™ And CobaCyte™ Oncology Research Displayed At The In

    ACCESS PHARMACEUTICALS, INC. (OTC Bulletin Board: ACCP), a biopharmaceutical company leveraging its proprietary drug-delivery platforms to develop treatments in areas of oncology, cancer supportive care and diabetes, announced that two oncology posters are being displayed this week at the...
Back
Top